ZA200906906B - Use of HDAC inhibitors for the treatment of melanoma - Google Patents

Use of HDAC inhibitors for the treatment of melanoma

Info

Publication number
ZA200906906B
ZA200906906B ZA200906906A ZA200906906A ZA200906906B ZA 200906906 B ZA200906906 B ZA 200906906B ZA 200906906 A ZA200906906 A ZA 200906906A ZA 200906906 A ZA200906906 A ZA 200906906A ZA 200906906 B ZA200906906 B ZA 200906906B
Authority
ZA
South Africa
Prior art keywords
melanoma
treatment
hdac inhibitors
hdac
inhibitors
Prior art date
Application number
ZA200906906A
Inventor
Peter Wisdom Atadja
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200906906B publication Critical patent/ZA200906906B/en

Links

ZA200906906A 2007-05-11 2009-10-05 Use of HDAC inhibitors for the treatment of melanoma ZA200906906B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91734507P 2007-05-11 2007-05-11

Publications (1)

Publication Number Publication Date
ZA200906906B true ZA200906906B (en) 2010-07-28

Family

ID=42738973

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200906906A ZA200906906B (en) 2007-05-11 2009-10-05 Use of HDAC inhibitors for the treatment of melanoma

Country Status (1)

Country Link
ZA (1) ZA200906906B (en)

Similar Documents

Publication Publication Date Title
EP2456757A4 (en) Hdac inhibitors and therapeutic methods using the same
EP2200439A4 (en) Hdac inhibitors
PL2205273T3 (en) Use of modified cells for the treatment of multiple sclerosis
HRP20181608T1 (en) Use of pde7 inhibitors for the treatment of movement disorders
IL197752A0 (en) Hdac inhibitors
ZA200801394B (en) Novel sulphonylpyrroles as inhibitors of HDAC S novel sulphonylpyrroles
EP2049505A4 (en) Isoform-selective hdac inhibitors
EP2202228A4 (en) Amide compounds and use of the same
EP2139475A4 (en) The use of pde7 inhibitors for the treatment of movement disorders
GB0823480D0 (en) Devices for the treatment of fluids
IL213694A0 (en) Melanin production inhibitor compounds and compositions comprising the same
PL1912640T3 (en) Use of the hdac inhibitor panobinostat for the treatment of myeloma
ZA201104146B (en) Dispersions comprising inhibitors of the hydroxyphenylpyruvate-dioxygenase
HRP20130395T1 (en) Treatment of melanoma
GB0813015D0 (en) Phosphoproteins and use of the same
ZA201100165B (en) Use of hdac inhibitors for the treatment of hodgkin's disease
GB0624187D0 (en) HDAC inhibitors
IL201466A0 (en) Use of hdac inhibitors for the treatment of bone destruction
IL194798A0 (en) Treatment of melanoma
IL215433A0 (en) Acrylamide compounds and the use thereof
EP2144615A4 (en) Methods of use of gamma inhibitor compounds for the attenuation of pain
IL201439A0 (en) Use of hdac inhibitors for the treatment of melanoma
ZA200906906B (en) Use of HDAC inhibitors for the treatment of melanoma
IL184620A0 (en) Composition for the treatment of inflammation
GB0809068D0 (en) The use of serine protease inhibitors